Optometry in Practice (OiP), the College's quarterly CPD journal, covers the latest research, analysis and opinion from your profession, and provides up to 4 CPD points.
This article reviews the use of topical beta-blockers for the treatment of glaucoma.
Although beta-blockers are no longer first choice for the treatment for glaucoma, they maintain a place in the treatment pathway. This article reviews the history and contemporary use of topical beta-blockers, and considers the range of alternative medical, laser and minimally invasive surgical options for glaucoma.
Sign in to continue
Sign in to view the article
Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
It has been over 15 years since prescribing rights were granted to optometrists, writes Dr Paramdeep Bilkhu MCOptom, Clinical Adviser for the College. How has this affected clinical practice and patient outcomes?